198 related articles for article (PubMed ID: 10389656)
1. Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.
Iwayama S; Ohmura Y; Suzuki K; Ono N; Nakazawa H; Aoki M; Tanabe I; Sekiyama T; Tsuji T; Okunishi M; Yamanishi K; Nishiyama Y
Antiviral Res; 1999 Jun; 42(2):139-48. PubMed ID: 10389656
[TBL] [Abstract][Full Text] [Related]
2. Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.
Neyts J; Naesens L; Ying C; De Bolle L; De Clercq E
Antiviral Res; 2001 Feb; 49(2):115-20. PubMed ID: 11248363
[TBL] [Abstract][Full Text] [Related]
3. Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.
Iwayama S; Ono N; Ohmura Y; Suzuki K; Aoki M; Nakazawa H; Oikawa M; Kato T; Okunishi M; Nishiyama Y; Yamanishi K
Antimicrob Agents Chemother; 1998 Jul; 42(7):1666-70. PubMed ID: 9661001
[TBL] [Abstract][Full Text] [Related]
4. The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.
Neyts J; De Clercq E
Antiviral Res; 2001 Feb; 49(2):121-7. PubMed ID: 11248364
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
6. Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice.
Sarisky RT; Bartus HR; Dennis SA; Quail MR; Nguyen TT; Wittrock RJ; Halsey WS; Bacon TH; Leary JJ; Sutton D
BMC Infect Dis; 2001; 1():24. PubMed ID: 11749671
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants.
Glorieux S; Vandekerckhove AP; Goris N; Yang XY; Steukers L; Van de Walle GR; Croubels S; Neyts J; Nauwynck HJ
Antiviral Res; 2012 Feb; 93(2):234-238. PubMed ID: 22178244
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
10. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
[TBL] [Abstract][Full Text] [Related]
11. Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir.
Kern ER; Richards JT; Glasgow LA; Overall JC; de Miranda P
Am J Med; 1982 Jul; 73(1A):125-31. PubMed ID: 7102699
[TBL] [Abstract][Full Text] [Related]
12. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice.
Park HJ; Kurokawa M; Shiraki K; Nakamura N; Choi JS; Hattori M
Biol Pharm Bull; 2005 Dec; 28(12):2258-62. PubMed ID: 16327161
[TBL] [Abstract][Full Text] [Related]
14. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals.
Boyd MR; Bacon TH; Sutton D
Antimicrob Agents Chemother; 1988 Mar; 32(3):358-63. PubMed ID: 3364954
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
16. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
Thackray AM; Field HJ
J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
Machida H; Ikeda T; Ashida N
Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
[TBL] [Abstract][Full Text] [Related]
19. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
Thackray AM; Field HJ
Antimicrob Agents Chemother; 1998 Jul; 42(7):1555-62. PubMed ID: 9660982
[TBL] [Abstract][Full Text] [Related]
20. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
